1. Home
  2. MRVI vs VBNK Comparison

MRVI vs VBNK Comparison

Compare MRVI & VBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • VBNK
  • Stock Information
  • Founded
  • MRVI 2014
  • VBNK 1980
  • Country
  • MRVI United States
  • VBNK Canada
  • Employees
  • MRVI N/A
  • VBNK N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • VBNK Commercial Banks
  • Sector
  • MRVI Health Care
  • VBNK Finance
  • Exchange
  • MRVI Nasdaq
  • VBNK Nasdaq
  • Market Cap
  • MRVI 312.4M
  • VBNK 373.6M
  • IPO Year
  • MRVI 2020
  • VBNK 2021
  • Fundamental
  • Price
  • MRVI $2.67
  • VBNK $11.39
  • Analyst Decision
  • MRVI Hold
  • VBNK Strong Buy
  • Analyst Count
  • MRVI 10
  • VBNK 4
  • Target Price
  • MRVI $6.84
  • VBNK $17.50
  • AVG Volume (30 Days)
  • MRVI 1.9M
  • VBNK 53.4K
  • Earning Date
  • MRVI 08-06-2025
  • VBNK 09-04-2025
  • Dividend Yield
  • MRVI N/A
  • VBNK 0.63%
  • EPS Growth
  • MRVI N/A
  • VBNK N/A
  • EPS
  • MRVI N/A
  • VBNK 0.79
  • Revenue
  • MRVI $241,856,000.00
  • VBNK $79,960,487.00
  • Revenue This Year
  • MRVI N/A
  • VBNK $12.97
  • Revenue Next Year
  • MRVI $10.62
  • VBNK $43.72
  • P/E Ratio
  • MRVI N/A
  • VBNK $14.30
  • Revenue Growth
  • MRVI N/A
  • VBNK N/A
  • 52 Week Low
  • MRVI $1.67
  • VBNK $8.51
  • 52 Week High
  • MRVI $10.03
  • VBNK $18.38
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 59.30
  • VBNK 59.18
  • Support Level
  • MRVI $2.52
  • VBNK $11.53
  • Resistance Level
  • MRVI $2.93
  • VBNK $11.75
  • Average True Range (ATR)
  • MRVI 0.18
  • VBNK 0.20
  • MACD
  • MRVI 0.03
  • VBNK 0.03
  • Stochastic Oscillator
  • MRVI 69.41
  • VBNK 90.77

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About VBNK VersaBank

VersaBank is a Canadian Schedule I chartered bank with a difference. It has 3 operating segments: Digital Banking Canada, Digital Banking USA and DRTC. It's, cloud-based, business-to-business deposit and lending model provides valued-added solutions to Canadian financial intermediary partners, enabling them to focus on growing their own businesses faster and more profitably. It obtains all of its deposits and provides the majority of its loans and leases electronically, with deposit and lending solutions for financial intermediaries that allow them to excel in their core businesses. In addition, leveraging its internally developed IT security software and capabilities, Company established a wholly owned, subsidiary. Geographically located in Canada and USA.

Share on Social Networks: